Near‐Infrared II Fluorescence Imaging Highlights Tumor Angiogenesis in Hepatocellular Carcinoma with a VEGFR‐Targeted Probe
Small Methods · 2025
DOI: 10.1002/smtd.202400904 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small Methods, 2025. Verfasst von Jiali Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, South China University of Technology, Guangzhou, Guangdong, 510006, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Neovascularization, Pathologic, Optical Imaging. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Guangdong Provincial People's Hospital Supporting Fund for Talent Program.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is typically characterized by rich vascularity, with angiogenesis playing a crucial role in its growth and invasion. Molecular imaging of specific receptors in blood vessels is crucial in HCC diagnosis. In particular, in vivo imaging utilizing the second near‐infrared (NIR‐II) window offers improved tissue penetration, reduced light scattering, and lower autofluorescence. Despite the great potential of the NIR‐II window, developing safe and effective probes to provide better imaging performance for HCC is urgently needed. In this study, NIR‐II imaging integrated with a vascular endothelial growth factor receptor (VEGFR)‐targeted probe generated by combining a VEGFR‐targeted peptide with indocyanine green (ICG) is used to characterize HCC‐related angiogenesis at a resolution of 56.0 µm. For the first time, liver metabolic curves and parameters of liver function reserve (LFR) are obtained by fitting NIR‐II fluorescence signals with high spatiotemporal resolution, showing significant differences between HCC mice and controls. Moreover, unlike ICG, the targeting probe has a targeted effect on blood vessels in vivo. The tumor‐to‐normal (T/N) ratio in NIR‐II imaging reaches up to 3.30 after post‐injection of the targeting probe. The results indicate that the VEGFR‐targeted probe is a powerful tool for NIR‐II fluorescence imaging to enhance early diagnosis of HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, South China University of Technology, Guangzhou, Guangdong, 510006, China.
- Medical Research Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
- Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510080, China.
ORCID-Profile: Liming Nie
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Guangdong Provincial People's Hospital Supporting Fund for Talent Program
- National Basic Research Program of China
Zitieren
APA
Chen, J., Li, S., Zhou, Q., Zhao, X., Fan, Z., Lo, H., & Nie, L. (2025). Near‐Infrared II Fluorescence Imaging Highlights Tumor Angiogenesis in Hepatocellular Carcinoma with a VEGFR‐Targeted Probe. Small Methods. https://doi.org/10.1002/smtd.202400904
Vancouver
Chen J, Li S, Zhou Q, Zhao X, Fan Z, Lo H, et al. Near‐Infrared II Fluorescence Imaging Highlights Tumor Angiogenesis in Hepatocellular Carcinoma with a VEGFR‐Targeted Probe. Small Methods. 2025. doi:10.1002/smtd.202400904
BibTeX
@article{Chen2025,
author = {Chen, Jiali and Li, Shiying and Zhou, Qi and Zhao, Xingyang and Fan, Zhijin and Lo, Hsuan and Nie, Liming},
title = {Near‐Infrared II Fluorescence Imaging Highlights Tumor Angiogenesis in Hepatocellular Carcinoma with a VEGFR‐Targeted Probe},
journal = {Small Methods},
year = {2025},
doi = {10.1002/smtd.202400904}
}
EUVIMED